Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sara Grammatico"'
Autor:
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, Gabriele Buda, Alessandro Gozzetti, Veronica Candi, Federico Simonetti, Maria Livia Del Giudice, Sara Ciofini, Michela Staderini, Sara Grammatico, Alessandra Buzzichelli, Maria Messeri, Monica Bocchia, Sara Galimberti, Alessandro M. Vannucchi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCarfilzomib, a potent, irreversible, selective proteasome inhibitor has demonstrated consistent results in relapsed/refractory multiple myeloma (RRMM) combined with lenalidomide and dexamethasone (KRd). No prospective studies are yet avai
Externí odkaz:
https://doaj.org/article/0187b91cd2a6449081286e4dd3695ef6
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 9, Iss 1, Pp e2017052-e2017052 (2017)
Solitary plasmacytoma is a rare disease characterized by a localized proliferation of neoplastic monoclonal plasma cells, without evidence of systemic disease. It can be subdivided into solitary bone plasmacytoma, if the lesion originates in bone, or
Externí odkaz:
https://doaj.org/article/5be347aac1fe4c82be555538d178d5dc
Autor:
Paolo Gorello, Roberta La Starza, Emanuela Varasano, Sabina Chiaretti, Loredana Elia, Valentina Pierini, Gianluca Barba, Lucia Brandimarte, Barbara Crescenzi, Antonella Vitale, Monica Messina, Sara Grammatico, Marco Mancini, Caterina Matteucci, Antonella Bardi, Anna Guarini, Massimo Fabrizio Martelli, Robin Foà, Cristina Mecucci
Publikováno v:
Haematologica, Vol 95, Iss 1 (2010)
Background Molecular lesions in T-cell acute lymphoblastic leukemias affect regulators of cell cycle, proliferation, differentiation, survival and apoptosis in multi-step pathogenic pathways. Full genetic characterization is needed to identify events
Externí odkaz:
https://doaj.org/article/7d36ef083f484e20b7442b4bf4a668ed
Autor:
Antonella Vitale, Sara Grammatico, Saveria Capria, Carina Fiocchi, Robin Foà, Giovanna Meloni
Publikováno v:
Haematologica, Vol 94, Iss 10 (2009)
Externí odkaz:
https://doaj.org/article/a2c9ff244d33445cb5443e247d6e3476
Autor:
Manuela Gambella, Barbara Gamberi, Pieter Sonneveld, Elona Saraci, Massimo Offidani, Antonio Palumbo, Alberto Rocci, Annalisa Bernardini, Vittorio Emanuele Muccio, Sara Grammatico, Mario Boccadoro, Stefano Spada, Paola Omedè, Rossella Troia, Concetta Conticello, Michele Cavo, Alessandra Larocca, Milena Gilestro, Anna Marina Liberati, Stefania Oliva
Publikováno v:
Cancer, 125(5), 750-760. John Wiley & Sons Inc.
Background: Minimal residual disease (MRD) is one of the most relevant prognostic factors in patients with multiple myeloma (MM); however, the impact of maintenance therapy on MRD levels remains unclear. Among patients with newly diagnosed MM (NDMM)
Autor:
Rita Rizzi, Francesco Pisani, Mario Boccadoro, Ombretta Annibali, Nicola Di Renzo, Annalisa Bernardini, Stefano Rocco, Magda Marcatti, Antonio Palumbo, Agostina Siniscalchi, Massimo Offidani, Roberto Vallone, Paola Ferrando, Stefano Spada, Salvatore Palmieri, Riccardo Centurioni, Emanuele Angelucci, Alessandra Larocca, Sergio Storti, Valerio De Stefano, Anna Baraldi, Sara Grammatico, Pellegrino Musto, Vittorio Meneghini, Andrea Evangelista, Enrico Aitini, Alessandro Andriani, Sara Bringhen, Angelo D. Palmas
Publikováno v:
Critical Reviews in Oncology/Hematology. 130:27-35
Early toxic death (≤60 days of diagnosis) in elderly multiple myeloma (MM) patients is attributable to active disease, age and co-morbidities. Rate of early toxic deaths is 10% with conventional chemotherapy mainly due to infection and renal failur
Autor:
Luca De Rosa, Agostina Siniscalchi, Laura Cesini, Alessia Fiorini, Maria Teresa Petrucci, Angela Rago, Sara Grammatico, Tommaso Caravita, Alessandro Andriani, Tommaso Za
Publikováno v:
European Journal of Haematology. 101:160-164
Objective The aim of this study was to evaluate the addition of cyclophosphamide in relapsed-refractory multiple myeloma patients (RRMM) who experienced biochemical relapse or progression without CRAB, during treatment with lenalidomide and dexametha
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:375-386
Introduction Multiple Myeloma (MM) management is rapidly evolving, with a spectrum of novel treatments that have changed our approach to the therapy. Proteasome inhibitors (PIs) have revolutionized the scenario of both relapsed/refractory and newly d
Autor:
Sara Grammatico, Roberto Foa, Alfonso Piciocchi, Marta Chisini, Maria Teresa Petrucci, Paola Finsinger
Publikováno v:
British Journal of Haematology. 172:554-560
This study aimed to review the clinical features and outcome of 53 patients with solitary plasmacytoma managed at our Institution between 1976 and 2012. Thirty-five patients had bone solitary plasmacytoma and 18 extramedullary solitary plasmacytoma.
Autor:
Federico Vozella, Maria Teresa Petrucci, Mario Boccadoro, Sara Bringhen, Sara Grammatico, Agostina Siniscalchi
Publikováno v:
Leukemia & Lymphoma. 58:2738-2740
Previously, we reported the efficacy and safety profile of bortezomib (1.3 mg/m2 weekly) associated to melphalan (24 mg for 28 days that is 2 mg on Monday–Wednesday–Friday every week), and predniso...